Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 70.45% ...

Nuvation Bio Inc (NUVB) stock saw a decline, ending the day at $2.9 which represents a decrease of $-0.17 or -5.54% from the prior close of $3.07. The stock opened at $3.05 and touched a low of $2.83 ...

Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today announced that management will ...

Fourth-quarter revenue of $0.73 million, up 64% year-over-year –- Full-year revenue of $3.11 million, up 148% year-over-year –- As of June 30, ...

SAN FRANCISCO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the "Company" or "89bio") (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of ...

JonesTrading analyst Soumit Roy has maintained their bullish stance on ACET stock, giving a Buy rating on September 11. Soumit Roy has given ...

SAN DIEGO (AP) — Telesis Bio, Inc. TBIO) on Wednesday reported a loss of $12.6 million in its second quarter. On a per-share basis, the San Diego-based company said it had a loss of $7.62.

Report with market evolution powered by AI- The global hepatitis b and c diagnostics market size is estimated to grow by USD ...

Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, announced the appointment of Matthias Will, M.D., as Chief ...

Mantle cell lymphoma is a rare and aggressive type of non-Hodgkin lymphoma originating from B-cells in the "mantle zone" of ...

Crocs achieved another circularity goal with the launch of its limited-edition Keep It Going Classic Clog. Each clog contains ...